The U.S. Anti-Doping Agency has flagged a pre-fight drug test given to them by Viscardi Andrade for the use of a banned substance.
Andrade (19-6) earned his third Octagon victory last month when he bested Richard Walsh in Australia. The drug test was provided 12 days before the bout to the USADA.
The UFC has released a statement on the matter:
The UFC organization was notified today that the U.S. Anti-Doping Agency (USADA) has informed Viscardi Andrade of a potential Anti-Doping Policy violation stemming from an out-of-competition sample collection on March 7, 2016. The sample was collected from Andrade in Brazil and analyzed at the WADA accredited laboratory in Rio de Janeiro, and recently reported to USADA as containing a prohibited substance.
USADA, the independent administrator of the UFC Anti-Doping Policy, will handle the results management and appropriate adjudication of this case involving Andrade. It is important to note that, under the UFC Anti-Doping Policy, there is a full and fair legal process that is afforded to all athletes before any sanctions are imposed, including any ruling on Andrade’s victory over Richard Walsh in Brisbane, Australia on March 20, 2016.
Additional information will be provided at the appropriate time as the process moves forward.